Flash FinanceUS
Pre-market S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Omnicell (OMCL)

Omnicell Q3 revenue rises 10% to $311 million; full-year revenue guidance raised

Mixed Impact 4 of 5 earnings Written later

Omnicell reported third quarter 2025 revenue of $311 million, up $28 million or 10% from a year earlier, and raised its full-year 2025 revenue, non-GAAP EBITDA and non-GAAP EPS guidance. Profit per share fell year over year on both GAAP and non-GAAP bases, so shareholders get higher sales and a higher outlook alongside lower quarterly earnings.

Key points

  • Q3 2025 total revenues were $311 million, up 10% from $282 million in Q3 2024.
  • GAAP net income was $5 million, or $0.12 per diluted share, versus $9 million, or $0.19, a year earlier.
  • Full-year 2025 total revenue guidance was raised to $1.177 billion-$1.187 billion; non-GAAP EPS guidance was raised to $1.63-$1.73.

The filing

CompanyOmnicell (OMCL)
Form8-K, current report
Filed with the SECOct 30, 2025, 6:35 AM ET
Accession number0000926326-25-000029

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.